6-Feb-2026 11:38 AM CST - Yahoo Finance A Look At Regeneron Pharmaceuticals (REGN) Valuation After Recent Share Price Pullback Has Been Trading Recently Regeneron Pharmaceuticals (REGN) has been moving within a mixed performance range, with a 1 day return of about a 1% decline, a 7 day gain of 3.4%, a month decline of 5.6%, and a past 3 months gain of 16.
31-Jan-2026 3:56 PM CST - Yahoo Finance Regeneron (REGN) Draws Higher Target From TD Cowen Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is included among the 13 Companies that Just Started Paying Dividends. During the Q4 2025 earnings call, CEO Leonard Schleifer said Regeneron Pharmaceuticals,
30-Jan-2026 10:43 AM CST - Yahoo Finance Regeneron Pharmaceuticals Q4 Earnings Call Highlights Regeneron Pharmaceuticals (NASDAQ:REGN) closed out 2025 with what executives described as another "solid quarter of commercial execution," highlighted by continued growth in Dupixent, Libtayo, and EYLEA HD,
20-Jan-2026 6:22 AM CST - Yahoo Finance A Look At Regeneron Pharmaceuticals (REGN) Valuation After Recent Share Price Momentum Regeneron Pharmaceuticals (REGN) has recently drawn attention after a period where the share price showed mixed short term returns but a stronger move over the past 3 months, prompting a closer look at its fundamentals.
14-Jan-2026 3:10 PM CST - Yahoo Finance UK Is Regeneron (REGN) Offering Value After Recent Share Price Swings? If you are wondering whether Regeneron Pharmaceuticals at around US$758.91 represents fair value or a potential opportunity right now, you are not alone. The stock has had mixed recent returns, with a 2.
6-Feb-2026 11:38 AM CST - Yahoo Finance A Look At Regeneron Pharmaceuticals (REGN) Valuation After Recent Share Price Pullback Has Been Trading Recently Regeneron Pharmaceuticals (REGN) has been moving within a mixed performance range, with a 1 day return of about a 1% decline, a 7 day gain of 3.4%, a month decline of 5.6%, and a past 3 months gain of 16.
31-Jan-2026 3:56 PM CST - Yahoo Finance Regeneron (REGN) Draws Higher Target From TD Cowen Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is included among the 13 Companies that Just Started Paying Dividends. During the Q4 2025 earnings call, CEO Leonard Schleifer said Regeneron Pharmaceuticals,
30-Jan-2026 10:43 AM CST - Yahoo Finance Regeneron Pharmaceuticals Q4 Earnings Call Highlights Regeneron Pharmaceuticals (NASDAQ:REGN) closed out 2025 with what executives described as another "solid quarter of commercial execution," highlighted by continued growth in Dupixent, Libtayo, and EYLEA HD,
20-Jan-2026 6:22 AM CST - Yahoo Finance A Look At Regeneron Pharmaceuticals (REGN) Valuation After Recent Share Price Momentum Regeneron Pharmaceuticals (REGN) has recently drawn attention after a period where the share price showed mixed short term returns but a stronger move over the past 3 months, prompting a closer look at its fundamentals.
14-Jan-2026 3:10 PM CST - Yahoo Finance UK Is Regeneron (REGN) Offering Value After Recent Share Price Swings? If you are wondering whether Regeneron Pharmaceuticals at around US$758.91 represents fair value or a potential opportunity right now, you are not alone. The stock has had mixed recent returns, with a 2.
